Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease

12 Jul 2014

Abstract excerpt

No treatment strategies effectively limit the progression of Alzheimer's disease (AD), a common and debilitating neurodegenerative disorder. The absence of viable treatment options reflects the fact that the pathophysiology and genotypic causes of the disease are not well understood. The advent of genome-wide association studies (GWAS) has made it possible to broadly investigate genotypic alterations driving...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25594051
DOI: 10.18632/oncoscience.64

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s diseasePMID 25594051Read ↗

Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated PathwaysSemantic proximity Read ↗

An Alzheimer’s disease-associated common regulatory variant in a PTK2B intron alters microglial functionSemantic proximity Read ↗

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.Semantic proximity Read ↗

The three new pathways leading to Alzheimer's disease.Semantic proximity Read ↗

PCDHA9 as a candidate gene for amyotrophic lateral sclerosisSemantic proximity Read ↗

Genome-wide association studies in Alzheimer's diseaseSemantic proximity Read ↗

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control studySemantic proximity Read ↗

Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.Semantic proximity Read ↗

The SHIP1-inflammatory-lipid axis in Alzheimer's disease: from genetic risk to spatiotemporal mechanistic insights.Semantic proximity Read ↗

Identification of functional non-coding variants affecting Alzheimer’s disease risk by Massively Parallel Reporter AssaySemantic proximity Read ↗

Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progressionSemantic proximity Read ↗

Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.